nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—urine—urinary bladder cancer	0.0451	0.146	CbGeAlD
Acetazolamide—AQP1—prostate gland—urinary bladder cancer	0.0162	0.0525	CbGeAlD
Acetazolamide—AQP1—seminal vesicle—urinary bladder cancer	0.0137	0.0444	CbGeAlD
Acetazolamide—AQP1—epithelium—urinary bladder cancer	0.0119	0.0386	CbGeAlD
Acetazolamide—CA3—prostate gland—urinary bladder cancer	0.0119	0.0385	CbGeAlD
Acetazolamide—AQP1—smooth muscle tissue—urinary bladder cancer	0.0115	0.0372	CbGeAlD
Acetazolamide—AQP1—renal system—urinary bladder cancer	0.011	0.0358	CbGeAlD
Acetazolamide—AQP1—urethra—urinary bladder cancer	0.0108	0.0352	CbGeAlD
Acetazolamide—CA14—prostate gland—urinary bladder cancer	0.0108	0.035	CbGeAlD
Acetazolamide—CA5A—female reproductive system—urinary bladder cancer	0.0106	0.0345	CbGeAlD
Acetazolamide—CA14—seminal vesicle—urinary bladder cancer	0.00912	0.0296	CbGeAlD
Acetazolamide—AQP1—female reproductive system—urinary bladder cancer	0.00884	0.0287	CbGeAlD
Acetazolamide—CA7—renal system—urinary bladder cancer	0.00882	0.0286	CbGeAlD
Acetazolamide—AQP1—vagina—urinary bladder cancer	0.00799	0.0259	CbGeAlD
Acetazolamide—CYP3A4—urine—urinary bladder cancer	0.00776	0.0252	CbGeAlD
Acetazolamide—CA5B—prostate gland—urinary bladder cancer	0.00754	0.0245	CbGeAlD
Acetazolamide—CA9—female reproductive system—urinary bladder cancer	0.00621	0.0201	CbGeAlD
Acetazolamide—CA3—vagina—urinary bladder cancer	0.00586	0.019	CbGeAlD
Acetazolamide—CA12—renal system—urinary bladder cancer	0.00573	0.0186	CbGeAlD
Acetazolamide—CA4—prostate gland—urinary bladder cancer	0.00521	0.0169	CbGeAlD
Acetazolamide—AQP1—lymph node—urinary bladder cancer	0.00517	0.0168	CbGeAlD
Acetazolamide—CA5B—urethra—urinary bladder cancer	0.00505	0.0164	CbGeAlD
Acetazolamide—CA12—female reproductive system—urinary bladder cancer	0.00459	0.0149	CbGeAlD
Acetazolamide—CA1—renal system—urinary bladder cancer	0.00454	0.0147	CbGeAlD
Acetazolamide—CA4—seminal vesicle—urinary bladder cancer	0.0044	0.0143	CbGeAlD
Acetazolamide—CA2—prostate gland—urinary bladder cancer	0.00432	0.014	CbGeAlD
Acetazolamide—CA5B—female reproductive system—urinary bladder cancer	0.00412	0.0134	CbGeAlD
Acetazolamide—CA3—lymph node—urinary bladder cancer	0.00379	0.0123	CbGeAlD
Acetazolamide—CA5B—vagina—urinary bladder cancer	0.00372	0.0121	CbGeAlD
Acetazolamide—CA2—seminal vesicle—urinary bladder cancer	0.00365	0.0119	CbGeAlD
Acetazolamide—CA1—female reproductive system—urinary bladder cancer	0.00364	0.0118	CbGeAlD
Acetazolamide—CA4—renal system—urinary bladder cancer	0.00355	0.0115	CbGeAlD
Acetazolamide—CA4—urethra—urinary bladder cancer	0.00349	0.0113	CbGeAlD
Acetazolamide—CA2—epithelium—urinary bladder cancer	0.00317	0.0103	CbGeAlD
Acetazolamide—CA2—smooth muscle tissue—urinary bladder cancer	0.00306	0.00992	CbGeAlD
Acetazolamide—CA2—renal system—urinary bladder cancer	0.00294	0.00955	CbGeAlD
Acetazolamide—CA4—female reproductive system—urinary bladder cancer	0.00284	0.00922	CbGeAlD
Acetazolamide—CA5B—lymph node—urinary bladder cancer	0.00241	0.00782	CbGeAlD
Acetazolamide—CA2—female reproductive system—urinary bladder cancer	0.00236	0.00765	CbGeAlD
Acetazolamide—CA2—vagina—urinary bladder cancer	0.00213	0.00692	CbGeAlD
Acetazolamide—CA1—lymph node—urinary bladder cancer	0.00213	0.0069	CbGeAlD
Acetazolamide—CYP3A4—renal system—urinary bladder cancer	0.0019	0.00616	CbGeAlD
Acetazolamide—CA4—lymph node—urinary bladder cancer	0.00166	0.0054	CbGeAlD
Acetazolamide—Blood disorder—Doxorubicin—urinary bladder cancer	0.00157	0.00375	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00156	0.00375	CcSEcCtD
Acetazolamide—Headache—Mitomycin—urinary bladder cancer	0.00156	0.00374	CcSEcCtD
Acetazolamide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00154	0.0037	CcSEcCtD
Acetazolamide—CYP3A4—female reproductive system—urinary bladder cancer	0.00152	0.00493	CbGeAlD
Acetazolamide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00152	0.00363	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00149	0.00357	CcSEcCtD
Acetazolamide—Nausea—Mitomycin—urinary bladder cancer	0.00148	0.00355	CcSEcCtD
Acetazolamide—Melaena—Methotrexate—urinary bladder cancer	0.00148	0.00354	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00146	0.00349	CcSEcCtD
Acetazolamide—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00145	0.00348	CcSEcCtD
Acetazolamide—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00142	0.0034	CcSEcCtD
Acetazolamide—Agitation—Thiotepa—urinary bladder cancer	0.00141	0.00338	CcSEcCtD
Acetazolamide—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.0014	0.00336	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.0014	0.00335	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—urinary bladder cancer	0.00138	0.00331	CcSEcCtD
Acetazolamide—CA2—lymph node—urinary bladder cancer	0.00138	0.00447	CbGeAlD
Acetazolamide—Leukopenia—Thiotepa—urinary bladder cancer	0.00138	0.00329	CcSEcCtD
Acetazolamide—Urine output increased—Methotrexate—urinary bladder cancer	0.00137	0.00327	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00134	0.0032	CcSEcCtD
Acetazolamide—Convulsion—Thiotepa—urinary bladder cancer	0.00133	0.00319	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00133	0.00318	CcSEcCtD
Acetazolamide—Agranulocytosis—Etoposide—urinary bladder cancer	0.00132	0.00316	CcSEcCtD
Acetazolamide—Tinnitus—Cisplatin—urinary bladder cancer	0.00129	0.00309	CcSEcCtD
Acetazolamide—Flushing—Cisplatin—urinary bladder cancer	0.00128	0.00308	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—urinary bladder cancer	0.00128	0.00306	CcSEcCtD
Acetazolamide—Confusional state—Thiotepa—urinary bladder cancer	0.00126	0.00303	CcSEcCtD
Acetazolamide—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00126	0.00302	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—urinary bladder cancer	0.00125	0.00299	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—urinary bladder cancer	0.00125	0.00299	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00123	0.00294	CcSEcCtD
Acetazolamide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00123	0.00294	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—urinary bladder cancer	0.00122	0.00292	CcSEcCtD
Acetazolamide—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.0012	0.00287	CcSEcCtD
Acetazolamide—Erythema multiforme—Etoposide—urinary bladder cancer	0.0012	0.00287	CcSEcCtD
Acetazolamide—Flushing—Etoposide—urinary bladder cancer	0.00118	0.00282	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00118	0.00281	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—urinary bladder cancer	0.00117	0.0028	CcSEcCtD
Acetazolamide—Malaise—Gemcitabine—urinary bladder cancer	0.00117	0.00279	CcSEcCtD
Acetazolamide—Leukopenia—Gemcitabine—urinary bladder cancer	0.00116	0.00277	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—urinary bladder cancer	0.00114	0.00274	CcSEcCtD
Acetazolamide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00114	0.00272	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00113	0.00272	CcSEcCtD
Acetazolamide—Paraesthesia—Thiotepa—urinary bladder cancer	0.00113	0.0027	CcSEcCtD
Acetazolamide—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00112	0.00268	CcSEcCtD
Acetazolamide—Somnolence—Thiotepa—urinary bladder cancer	0.00111	0.00267	CcSEcCtD
Acetazolamide—Dyspepsia—Thiotepa—urinary bladder cancer	0.0011	0.00264	CcSEcCtD
Acetazolamide—Convulsion—Fluorouracil—urinary bladder cancer	0.0011	0.00264	CcSEcCtD
Acetazolamide—Decreased appetite—Thiotepa—urinary bladder cancer	0.00109	0.00261	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00109	0.0026	CcSEcCtD
Acetazolamide—Discomfort—Gemcitabine—urinary bladder cancer	0.00109	0.0026	CcSEcCtD
Acetazolamide—Malaise—Cisplatin—urinary bladder cancer	0.00109	0.0026	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00108	0.00259	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—urinary bladder cancer	0.00108	0.00259	CcSEcCtD
Acetazolamide—Fatigue—Thiotepa—urinary bladder cancer	0.00108	0.00259	CcSEcCtD
Acetazolamide—Dysgeusia—Etoposide—urinary bladder cancer	0.00108	0.00259	CcSEcCtD
Acetazolamide—Leukopenia—Cisplatin—urinary bladder cancer	0.00108	0.00258	CcSEcCtD
Acetazolamide—Discomfort—Fluorouracil—urinary bladder cancer	0.00107	0.00256	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00106	0.00254	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—urinary bladder cancer	0.00106	0.00253	CcSEcCtD
Acetazolamide—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00105	0.00253	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00105	0.00252	CcSEcCtD
Acetazolamide—Irritability—Methotrexate—urinary bladder cancer	0.00105	0.00251	CcSEcCtD
Acetazolamide—Confusional state—Fluorouracil—urinary bladder cancer	0.00105	0.0025	CcSEcCtD
Acetazolamide—Convulsion—Cisplatin—urinary bladder cancer	0.00104	0.0025	CcSEcCtD
Acetazolamide—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00104	0.00248	CcSEcCtD
Acetazolamide—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00103	0.00247	CcSEcCtD
Acetazolamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00103	0.00247	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—urinary bladder cancer	0.00103	0.00247	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—urinary bladder cancer	0.00103	0.00247	CcSEcCtD
Acetazolamide—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00102	0.00245	CcSEcCtD
Acetazolamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00102	0.00243	CcSEcCtD
Acetazolamide—Discomfort—Cisplatin—urinary bladder cancer	0.00101	0.00243	CcSEcCtD
Acetazolamide—Urticaria—Thiotepa—urinary bladder cancer	0.000996	0.00239	CcSEcCtD
Acetazolamide—Malaise—Etoposide—urinary bladder cancer	0.000995	0.00238	CcSEcCtD
Acetazolamide—Body temperature increased—Thiotepa—urinary bladder cancer	0.000991	0.00237	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000988	0.00237	CcSEcCtD
Acetazolamide—Leukopenia—Etoposide—urinary bladder cancer	0.000988	0.00237	CcSEcCtD
Acetazolamide—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000983	0.00235	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000982	0.00235	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000974	0.00233	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—urinary bladder cancer	0.000966	0.00231	CcSEcCtD
Acetazolamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000963	0.00231	CcSEcCtD
Acetazolamide—Convulsion—Etoposide—urinary bladder cancer	0.000956	0.00229	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000954	0.00229	CcSEcCtD
Acetazolamide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000947	0.00227	CcSEcCtD
Acetazolamide—Somnolence—Gemcitabine—urinary bladder cancer	0.000938	0.00225	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000935	0.00224	CcSEcCtD
Acetazolamide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000931	0.00223	CcSEcCtD
Acetazolamide—Discomfort—Etoposide—urinary bladder cancer	0.000928	0.00222	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000925	0.00222	CcSEcCtD
Acetazolamide—Somnolence—Fluorouracil—urinary bladder cancer	0.000922	0.00221	CcSEcCtD
Acetazolamide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000917	0.0022	CcSEcCtD
Acetazolamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000913	0.00219	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000911	0.00218	CcSEcCtD
Acetazolamide—Fatigue—Gemcitabine—urinary bladder cancer	0.000909	0.00218	CcSEcCtD
Acetazolamide—Confusional state—Etoposide—urinary bladder cancer	0.000908	0.00217	CcSEcCtD
Acetazolamide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000901	0.00216	CcSEcCtD
Acetazolamide—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000901	0.00216	CcSEcCtD
Acetazolamide—Asthenia—Thiotepa—urinary bladder cancer	0.0009	0.00215	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000895	0.00214	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—urinary bladder cancer	0.000894	0.00214	CcSEcCtD
Acetazolamide—Paraesthesia—Cisplatin—urinary bladder cancer	0.000883	0.00211	CcSEcCtD
Acetazolamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000882	0.00211	CcSEcCtD
Acetazolamide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000869	0.00208	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000866	0.00207	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000865	0.00207	CcSEcCtD
Acetazolamide—Diarrhoea—Thiotepa—urinary bladder cancer	0.000858	0.00205	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000856	0.00205	CcSEcCtD
Acetazolamide—Decreased appetite—Cisplatin—urinary bladder cancer	0.000855	0.00205	CcSEcCtD
Acetazolamide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000855	0.00205	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000849	0.00203	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—urinary bladder cancer	0.000846	0.00203	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000839	0.00201	CcSEcCtD
Acetazolamide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000834	0.002	CcSEcCtD
Acetazolamide—Dizziness—Thiotepa—urinary bladder cancer	0.000829	0.00199	CcSEcCtD
Acetazolamide—Urticaria—Fluorouracil—urinary bladder cancer	0.000824	0.00197	CcSEcCtD
Acetazolamide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00082	0.00196	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00081	0.00194	CcSEcCtD
Acetazolamide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00081	0.00194	CcSEcCtD
Acetazolamide—Paraesthesia—Etoposide—urinary bladder cancer	0.000809	0.00194	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—urinary bladder cancer	0.000806	0.00193	CcSEcCtD
Acetazolamide—Somnolence—Etoposide—urinary bladder cancer	0.000801	0.00192	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.0008	0.00192	CcSEcCtD
Acetazolamide—Vomiting—Thiotepa—urinary bladder cancer	0.000797	0.00191	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—urinary bladder cancer	0.000792	0.0019	CcSEcCtD
Acetazolamide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000789	0.00189	CcSEcCtD
Acetazolamide—Headache—Thiotepa—urinary bladder cancer	0.000785	0.00188	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000785	0.00188	CcSEcCtD
Acetazolamide—Decreased appetite—Etoposide—urinary bladder cancer	0.000783	0.00187	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000778	0.00186	CcSEcCtD
Acetazolamide—Body temperature increased—Cisplatin—urinary bladder cancer	0.000777	0.00186	CcSEcCtD
Acetazolamide—Fatigue—Etoposide—urinary bladder cancer	0.000776	0.00186	CcSEcCtD
Acetazolamide—Asthenia—Gemcitabine—urinary bladder cancer	0.000757	0.00181	CcSEcCtD
Acetazolamide—Haematuria—Epirubicin—urinary bladder cancer	0.000755	0.00181	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00075	0.0018	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000749	0.00179	CcSEcCtD
Acetazolamide—Nausea—Thiotepa—urinary bladder cancer	0.000745	0.00178	CcSEcCtD
Acetazolamide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000742	0.00178	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000739	0.00177	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—urinary bladder cancer	0.000732	0.00175	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000726	0.00174	CcSEcCtD
Acetazolamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000722	0.00173	CcSEcCtD
Acetazolamide—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000718	0.00172	CcSEcCtD
Acetazolamide—Urticaria—Etoposide—urinary bladder cancer	0.000715	0.00171	CcSEcCtD
Acetazolamide—Body temperature increased—Etoposide—urinary bladder cancer	0.000712	0.0017	CcSEcCtD
Acetazolamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00071	0.0017	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—urinary bladder cancer	0.000708	0.0017	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000707	0.00169	CcSEcCtD
Acetazolamide—Asthenia—Cisplatin—urinary bladder cancer	0.000705	0.00169	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—urinary bladder cancer	0.000698	0.00167	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000693	0.00166	CcSEcCtD
Acetazolamide—Dizziness—Fluorouracil—urinary bladder cancer	0.000686	0.00164	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000683	0.00164	CcSEcCtD
Acetazolamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000673	0.00161	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000672	0.00161	CcSEcCtD
Acetazolamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000671	0.00161	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—urinary bladder cancer	0.000663	0.00159	CcSEcCtD
Acetazolamide—Headache—Gemcitabine—urinary bladder cancer	0.000661	0.00158	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—urinary bladder cancer	0.000659	0.00158	CcSEcCtD
Acetazolamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000659	0.00158	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000654	0.00157	CcSEcCtD
Acetazolamide—Headache—Fluorouracil—urinary bladder cancer	0.00065	0.00156	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—urinary bladder cancer	0.000647	0.00155	CcSEcCtD
Acetazolamide—Asthenia—Etoposide—urinary bladder cancer	0.000646	0.00155	CcSEcCtD
Acetazolamide—Nausea—Gemcitabine—urinary bladder cancer	0.000626	0.0015	CcSEcCtD
Acetazolamide—Vomiting—Cisplatin—urinary bladder cancer	0.000625	0.0015	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000622	0.00149	CcSEcCtD
Acetazolamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000616	0.00148	CcSEcCtD
Acetazolamide—Nausea—Fluorouracil—urinary bladder cancer	0.000616	0.00148	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000613	0.00147	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000613	0.00147	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—urinary bladder cancer	0.00061	0.00146	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000606	0.00145	CcSEcCtD
Acetazolamide—Malaise—Methotrexate—urinary bladder cancer	0.000596	0.00143	CcSEcCtD
Acetazolamide—Dizziness—Etoposide—urinary bladder cancer	0.000596	0.00143	CcSEcCtD
Acetazolamide—Leukopenia—Methotrexate—urinary bladder cancer	0.000592	0.00142	CcSEcCtD
Acetazolamide—Nausea—Cisplatin—urinary bladder cancer	0.000584	0.0014	CcSEcCtD
Acetazolamide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000574	0.00137	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—urinary bladder cancer	0.000573	0.00137	CcSEcCtD
Acetazolamide—Vomiting—Etoposide—urinary bladder cancer	0.000573	0.00137	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—urinary bladder cancer	0.000568	0.00136	CcSEcCtD
Acetazolamide—Headache—Etoposide—urinary bladder cancer	0.000564	0.00135	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00056	0.00134	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—urinary bladder cancer	0.000558	0.00134	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—urinary bladder cancer	0.000556	0.00133	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—urinary bladder cancer	0.000554	0.00133	CcSEcCtD
Acetazolamide—Confusional state—Methotrexate—urinary bladder cancer	0.000544	0.0013	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000539	0.00129	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—urinary bladder cancer	0.000536	0.00128	CcSEcCtD
Acetazolamide—Nausea—Etoposide—urinary bladder cancer	0.000535	0.00128	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000531	0.00127	CcSEcCtD
Acetazolamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000528	0.00126	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—urinary bladder cancer	0.000526	0.00126	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—urinary bladder cancer	0.00052	0.00125	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—urinary bladder cancer	0.000516	0.00124	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000512	0.00123	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—urinary bladder cancer	0.000509	0.00122	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000505	0.00121	CcSEcCtD
Acetazolamide—Shock—Epirubicin—urinary bladder cancer	0.000497	0.00119	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—urinary bladder cancer	0.000496	0.00119	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000494	0.00118	CcSEcCtD
Acetazolamide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000484	0.00116	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—urinary bladder cancer	0.000481	0.00115	CcSEcCtD
Acetazolamide—Somnolence—Methotrexate—urinary bladder cancer	0.00048	0.00115	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000475	0.00114	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—urinary bladder cancer	0.000471	0.00113	CcSEcCtD
Acetazolamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000469	0.00112	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000467	0.00112	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000466	0.00112	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—urinary bladder cancer	0.000465	0.00111	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—urinary bladder cancer	0.00046	0.0011	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000457	0.0011	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000453	0.00109	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—urinary bladder cancer	0.000449	0.00107	CcSEcCtD
Acetazolamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000445	0.00106	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000444	0.00106	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000439	0.00105	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000436	0.00104	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—urinary bladder cancer	0.000435	0.00104	CcSEcCtD
Acetazolamide—Urticaria—Methotrexate—urinary bladder cancer	0.000429	0.00103	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000426	0.00102	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000419	0.001	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000416	0.000996	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000415	0.000994	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000411	0.000985	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000406	0.000972	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000403	0.000966	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—urinary bladder cancer	0.000403	0.000964	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—urinary bladder cancer	0.000401	0.00096	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000399	0.000956	CcSEcCtD
Acetazolamide—Asthenia—Methotrexate—urinary bladder cancer	0.000387	0.000927	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000385	0.000922	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—urinary bladder cancer	0.000371	0.000889	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000369	0.000884	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000369	0.000884	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—urinary bladder cancer	0.000362	0.000867	CcSEcCtD
Acetazolamide—Dizziness—Methotrexate—urinary bladder cancer	0.000357	0.000854	CcSEcCtD
Acetazolamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000345	0.000827	CcSEcCtD
Acetazolamide—Vomiting—Methotrexate—urinary bladder cancer	0.000343	0.000821	CcSEcCtD
Acetazolamide—Headache—Methotrexate—urinary bladder cancer	0.000338	0.000809	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000335	0.000803	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—urinary bladder cancer	0.000334	0.000799	CcSEcCtD
Acetazolamide—CA14—Metabolism—RRM2—urinary bladder cancer	0.000333	0.00122	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.00033	0.0012	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GPX1—urinary bladder cancer	0.000327	0.00119	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NAT2—urinary bladder cancer	0.000325	0.00119	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—RRM2—urinary bladder cancer	0.000325	0.00118	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—RRM2—urinary bladder cancer	0.000325	0.00118	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GSTP1—urinary bladder cancer	0.000322	0.00117	CbGpPWpGaD
Acetazolamide—Vomiting—Epirubicin—urinary bladder cancer	0.000321	0.000769	CcSEcCtD
Acetazolamide—AQP1—Metabolism—ERCC2—urinary bladder cancer	0.000321	0.00117	CbGpPWpGaD
Acetazolamide—Nausea—Methotrexate—urinary bladder cancer	0.00032	0.000767	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00032	0.000765	CcSEcCtD
Acetazolamide—Headache—Epirubicin—urinary bladder cancer	0.000316	0.000757	CcSEcCtD
Acetazolamide—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.000315	0.00115	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.00031	0.00113	CbGpPWpGaD
Acetazolamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000309	0.00074	CcSEcCtD
Acetazolamide—CA14—Metabolism—HPGDS—urinary bladder cancer	0.000309	0.00113	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ENO2—urinary bladder cancer	0.000309	0.00113	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000306	0.00112	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—RRM2—urinary bladder cancer	0.000303	0.00111	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—RRM2—urinary bladder cancer	0.000303	0.00111	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—MTHFR—urinary bladder cancer	0.000302	0.0011	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—HPGDS—urinary bladder cancer	0.000301	0.0011	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—HPGDS—urinary bladder cancer	0.000301	0.0011	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ENO2—urinary bladder cancer	0.000301	0.0011	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ENO2—urinary bladder cancer	0.000301	0.0011	CbGpPWpGaD
Acetazolamide—Nausea—Epirubicin—urinary bladder cancer	0.0003	0.000718	CcSEcCtD
Acetazolamide—CA14—Metabolism—GSTT1—urinary bladder cancer	0.000299	0.00109	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—TYMS—urinary bladder cancer	0.000299	0.00109	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.000298	0.00109	CbGpPWpGaD
Acetazolamide—Vomiting—Doxorubicin—urinary bladder cancer	0.000297	0.000711	CcSEcCtD
Acetazolamide—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000296	0.00108	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—NCOR1—urinary bladder cancer	0.000296	0.00108	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GSTM1—urinary bladder cancer	0.000296	0.00108	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.000295	0.00108	CbGpPWpGaD
Acetazolamide—Headache—Doxorubicin—urinary bladder cancer	0.000293	0.000701	CcSEcCtD
Acetazolamide—CA5A—Metabolism—GSTT1—urinary bladder cancer	0.000292	0.00106	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTT1—urinary bladder cancer	0.000292	0.00106	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PRSS3—urinary bladder cancer	0.00029	0.00106	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000289	0.00105	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000287	0.00105	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GPX1—urinary bladder cancer	0.000283	0.00103	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—RRM2—urinary bladder cancer	0.000281	0.00102	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.000281	0.00102	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—HPGDS—urinary bladder cancer	0.000281	0.00102	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ENO2—urinary bladder cancer	0.000281	0.00102	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ENO2—urinary bladder cancer	0.000281	0.00102	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ERCC2—urinary bladder cancer	0.000278	0.00101	CbGpPWpGaD
Acetazolamide—Nausea—Doxorubicin—urinary bladder cancer	0.000277	0.000664	CcSEcCtD
Acetazolamide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000275	0.001	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.000272	0.000993	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTT1—urinary bladder cancer	0.000272	0.000993	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000267	0.000975	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMP—urinary bladder cancer	0.000264	0.000962	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—MTHFR—urinary bladder cancer	0.000262	0.000954	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ENO2—urinary bladder cancer	0.00026	0.000949	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HPGDS—urinary bladder cancer	0.00026	0.000949	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NAT2—urinary bladder cancer	0.00026	0.000947	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000259	0.000945	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTT1—urinary bladder cancer	0.000252	0.00092	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000249	0.000907	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NQO1—urinary bladder cancer	0.000249	0.000907	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PPARG—urinary bladder cancer	0.000245	0.000892	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NQO1—urinary bladder cancer	0.000243	0.000884	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NQO1—urinary bladder cancer	0.000243	0.000884	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NAT2—urinary bladder cancer	0.000239	0.00087	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000235	0.000857	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CREBBP—urinary bladder cancer	0.000235	0.000857	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMP—urinary bladder cancer	0.000232	0.000846	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000226	0.000826	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NQO1—urinary bladder cancer	0.000226	0.000826	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—RRM2—urinary bladder cancer	0.000224	0.000817	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—RRM2—urinary bladder cancer	0.000215	0.000783	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PPARG—urinary bladder cancer	0.000212	0.000774	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000212	0.000773	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NAT2—urinary bladder cancer	0.00021	0.000765	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NQO1—urinary bladder cancer	0.00021	0.000765	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTP1—urinary bladder cancer	0.000208	0.000757	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000208	0.000757	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ENO2—urinary bladder cancer	0.000208	0.000757	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000206	0.000753	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000206	0.000751	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CREBBP—urinary bladder cancer	0.000204	0.000743	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000204	0.000743	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTP1—urinary bladder cancer	0.000202	0.000738	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTP1—urinary bladder cancer	0.000202	0.000738	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000202	0.000735	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000201	0.000734	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000199	0.000725	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000199	0.000725	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000195	0.000712	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TYMS—urinary bladder cancer	0.000193	0.000704	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000193	0.000704	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTGS2—urinary bladder cancer	0.000192	0.000702	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.000191	0.000696	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ENO2—urinary bladder cancer	0.000191	0.000696	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTM1—urinary bladder cancer	0.000191	0.000696	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NCOR1—urinary bladder cancer	0.000191	0.000696	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000189	0.000689	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTP1—urinary bladder cancer	0.000189	0.000689	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TYMS—urinary bladder cancer	0.000188	0.000686	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TYMS—urinary bladder cancer	0.000188	0.000686	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTM1—urinary bladder cancer	0.000186	0.000678	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTM1—urinary bladder cancer	0.000186	0.000678	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NCOR1—urinary bladder cancer	0.000186	0.000678	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NCOR1—urinary bladder cancer	0.000186	0.000678	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.000185	0.000675	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GPX1—urinary bladder cancer	0.000183	0.000666	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—RRM2—urinary bladder cancer	0.000181	0.00066	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ERCC2—urinary bladder cancer	0.000179	0.000654	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GPX1—urinary bladder cancer	0.000178	0.000649	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GPX1—urinary bladder cancer	0.000178	0.000649	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TYMS—urinary bladder cancer	0.000176	0.00064	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TYMS—urinary bladder cancer	0.000176	0.00064	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTP1—urinary bladder cancer	0.000175	0.000638	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ERCC2—urinary bladder cancer	0.000175	0.000637	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ERCC2—urinary bladder cancer	0.000175	0.000637	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NCOR1—urinary bladder cancer	0.000174	0.000633	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTM1—urinary bladder cancer	0.000174	0.000633	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTM1—urinary bladder cancer	0.000174	0.000633	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NCOR1—urinary bladder cancer	0.000174	0.000633	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—MTHFR—urinary bladder cancer	0.000169	0.000615	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTEN—urinary bladder cancer	0.000168	0.000612	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ENO2—urinary bladder cancer	0.000168	0.000611	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HPGDS—urinary bladder cancer	0.000168	0.000611	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NQO1—urinary bladder cancer	0.000167	0.00061	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—urinary bladder cancer	0.000167	0.000609	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GPX1—urinary bladder cancer	0.000166	0.000606	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GPX1—urinary bladder cancer	0.000166	0.000606	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000165	0.000602	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—MTHFR—urinary bladder cancer	0.000164	0.000599	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—MTHFR—urinary bladder cancer	0.000164	0.000599	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ERCC2—urinary bladder cancer	0.000163	0.000595	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ERCC2—urinary bladder cancer	0.000163	0.000595	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTT1—urinary bladder cancer	0.000163	0.000593	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TYMS—urinary bladder cancer	0.000163	0.000593	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTM1—urinary bladder cancer	0.000161	0.000586	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NCOR1—urinary bladder cancer	0.000161	0.000586	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NQO1—urinary bladder cancer	0.00016	0.000585	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.00016	0.000584	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—EP300—urinary bladder cancer	0.00016	0.000584	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GPX1—urinary bladder cancer	0.000154	0.000561	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NQO1—urinary bladder cancer	0.000154	0.000561	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—MTHFR—urinary bladder cancer	0.000153	0.000559	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—MTHFR—urinary bladder cancer	0.000153	0.000559	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ERCC2—urinary bladder cancer	0.000151	0.000551	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTEN—urinary bladder cancer	0.000146	0.000531	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—urinary bladder cancer	0.000144	0.000526	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—MTHFR—urinary bladder cancer	0.000142	0.000518	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTP1—urinary bladder cancer	0.00014	0.000509	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—EP300—urinary bladder cancer	0.000139	0.000506	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARG—urinary bladder cancer	0.000137	0.000498	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NQO1—urinary bladder cancer	0.000135	0.000493	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTP1—urinary bladder cancer	0.000134	0.000488	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARG—urinary bladder cancer	0.000133	0.000486	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARG—urinary bladder cancer	0.000133	0.000486	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CREBBP—urinary bladder cancer	0.000131	0.000479	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TYMS—urinary bladder cancer	0.00013	0.000473	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTP1—urinary bladder cancer	0.000128	0.000468	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000128	0.000467	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000128	0.000467	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CREBBP—urinary bladder cancer	0.000128	0.000467	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CREBBP—urinary bladder cancer	0.000128	0.000467	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARG—urinary bladder cancer	0.000124	0.000453	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARG—urinary bladder cancer	0.000124	0.000453	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TYMS—urinary bladder cancer	0.000124	0.000453	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000123	0.000448	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000123	0.000448	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GPX1—urinary bladder cancer	0.000123	0.000448	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ERCC2—urinary bladder cancer	0.000121	0.00044	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CREBBP—urinary bladder cancer	0.000119	0.000436	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CREBBP—urinary bladder cancer	0.000119	0.000436	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMS—urinary bladder cancer	0.000119	0.000435	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NCOR1—urinary bladder cancer	0.000118	0.00043	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTM1—urinary bladder cancer	0.000118	0.00043	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GPX1—urinary bladder cancer	0.000118	0.000429	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000116	0.000421	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARG—urinary bladder cancer	0.000115	0.00042	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000113	0.000413	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GPX1—urinary bladder cancer	0.000113	0.000412	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTP1—urinary bladder cancer	0.000113	0.000411	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000111	0.000405	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ERCC2—urinary bladder cancer	0.000111	0.000404	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CREBBP—urinary bladder cancer	0.000111	0.000404	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000109	0.000399	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—urinary bladder cancer	0.000109	0.000396	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—urinary bladder cancer	0.000108	0.000392	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMS—urinary bladder cancer	0.000105	0.000382	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—urinary bladder cancer	0.000105	0.000382	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—urinary bladder cancer	0.000105	0.000382	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—urinary bladder cancer	0.000104	0.00038	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NCOR1—urinary bladder cancer	0.000104	0.000378	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTM1—urinary bladder cancer	0.000104	0.000378	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000102	0.000372	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000101	0.000367	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GPX1—urinary bladder cancer	9.92e-05	0.000362	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—urinary bladder cancer	9.78e-05	0.000357	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—urinary bladder cancer	9.78e-05	0.000357	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ERCC2—urinary bladder cancer	9.74e-05	0.000355	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTEN—urinary bladder cancer	9.38e-05	0.000342	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARG—urinary bladder cancer	9.19e-05	0.000335	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—urinary bladder cancer	9.16e-05	0.000334	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTEN—urinary bladder cancer	9.14e-05	0.000333	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTEN—urinary bladder cancer	9.14e-05	0.000333	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.14e-05	0.000333	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—urinary bladder cancer	9.06e-05	0.00033	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—EP300—urinary bladder cancer	8.94e-05	0.000326	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CREBBP—urinary bladder cancer	8.83e-05	0.000322	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARG—urinary bladder cancer	8.81e-05	0.000321	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—EP300—urinary bladder cancer	8.72e-05	0.000318	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—EP300—urinary bladder cancer	8.72e-05	0.000318	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTEN—urinary bladder cancer	8.53e-05	0.000311	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTEN—urinary bladder cancer	8.53e-05	0.000311	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CREBBP—urinary bladder cancer	8.46e-05	0.000309	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARG—urinary bladder cancer	8.44e-05	0.000308	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—EP300—urinary bladder cancer	8.14e-05	0.000297	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—EP300—urinary bladder cancer	8.14e-05	0.000297	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CREBBP—urinary bladder cancer	8.11e-05	0.000296	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTEN—urinary bladder cancer	7.9e-05	0.000288	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—EP300—urinary bladder cancer	7.54e-05	0.000275	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARG—urinary bladder cancer	7.42e-05	0.000271	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—urinary bladder cancer	7.23e-05	0.000264	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CREBBP—urinary bladder cancer	7.13e-05	0.00026	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—urinary bladder cancer	6.93e-05	0.000253	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.8e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—urinary bladder cancer	6.64e-05	0.000242	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.44e-05	0.000235	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.44e-05	0.000235	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTEN—urinary bladder cancer	6.3e-05	0.00023	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTEN—urinary bladder cancer	6.04e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—EP300—urinary bladder cancer	6.01e-05	0.000219	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.89e-05	0.000215	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—urinary bladder cancer	5.84e-05	0.000213	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTEN—urinary bladder cancer	5.79e-05	0.000211	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—EP300—urinary bladder cancer	5.76e-05	0.00021	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—EP300—urinary bladder cancer	5.53e-05	0.000201	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.31e-05	0.000194	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTEN—urinary bladder cancer	5.09e-05	0.000186	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.01e-05	0.000183	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.88e-05	0.000178	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—EP300—urinary bladder cancer	4.86e-05	0.000177	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.9e-05	0.000142	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.53e-05	0.000129	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.05e-05	0.000111	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.82e-05	0.000103	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.82e-05	0.000103	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.74e-05	9.98e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.28e-05	8.3e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.9e-05	6.92e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.76e-05	6.43e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.74e-05	6.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.74e-05	6.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.67e-05	6.09e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.64e-05	5.98e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.54e-05	5.62e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.25e-05	4.56e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.2e-05	4.38e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.83e-06	3.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.57e-06	3.13e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.18e-06	2.98e-05	CbGpPWpGaD
